Alternative splicing is an important mechanism behind KAI1 loss of function in breast cancer patients from Saudi Arabia
- 10 October 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 173 (1) , 87-91
Abstract
Purpose KAI1 (also called CD82) is a metastasis suppressor gene known to be downregulated in breast cancer and other solid tumors. The downregulation of KAI1 or loss of its function is usually associated with bad prognosis. The mechanism behind KAI1 loss of function is complex. In this study, we investigated “alternative splicing” as a possible mechanism that underlies KAI1 loss of function in breast cancer patients from a tertiary hospital in Saudi Arabia. Methods Expression of KAI1 was studied in FFPE breast cancer and control tissue sections by IHC using two different antibodies targeting different domains of the protein. The TS82B antibody targets the extracellular loop, which constitutes most of the protein, while the second EPR4112 antibody targets the C-terminal intracellular domain of the protein. Results Out of 90 breast cancer samples, 67% showed loss of KAI1 expression. The remaining 33% showed KAI1 expression with (TS82B) antibody; however, the protein was detected in only 11% of cancers when using the antibody (EPR4112) indicating a truncation of the protein at the C-terminus (truncated-KAI1) in 22% of the studied cancer samples. A significant correlation was found between truncated-KAI1 expression and advanced cancer stage (association with lymph node metastasis, P value 0.008). Conclusion Alternative splicing is an important mechanism underlying KAI1 loss of function in breast cancer, and it is associated with bad prognosis (advanced cancer stage).Keywords
Funding Information
- University of Dammam (2015192)
This publication has 19 references indexed in Scilit:
- Papillary Carcinoma of the Thyroid: High Expression of COX-2 and Low Expression of KAI-1/CD82 Are Associated with Increased Tumor InvasivenessThyroid®, 2013
- Dissecting the diverse functions of the metastasis suppressor CD82/KAI1FEBS Letters, 2011
- Metastasis Suppressor KAI1/CD82 Attenuates the Matrix Adhesion of Human Prostate Cancer Cells by Suppressing Fibronectin Expression and β 1 Integrin ActivationCellular Physiology and Biochemistry, 2011
- Expression of KAI1/CD82 in distant metastases from estrogen receptor‐negative breast cancerCancer Science, 2009
- CD82 endocytosis and cholesterol‐dependent reorganization of tetraspanin webs and lipid raftsThe FASEB Journal, 2009
- Transmembrane Interactions Are Needed for KAI1/CD82-Mediated Suppression of Cancer Invasion and MetastasisThe American Journal of Pathology, 2009
- KAI1/CD82 is a novel target of estrogen receptor‐mediated gene repression and downregulated in primary human breast cancerInternational Journal of Cancer, 2008
- KAI1/CD82, a tumor metastasis suppressorCancer Letters, 2006
- CD82 metastasis suppressor gene: a potential target for new therapeutics?Trends in Molecular Medicine, 2005
- Defining regulatory elements in the humanKAI1 (CD 82) metastasis suppressor geneThe Prostate, 2003